The RAF proteins take centre stage

Nature Reviews Molecular Cell Biology

Volumn 5, Issue 11, 2004, Pages 875-885

  Wellbrock, Claudia ^a   Karasarides, Maria ^b   Marais, Richard ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; ISOPROTEIN; PROTEIN C RAF; PROTEIN KINASE; RAF PROTEIN; RAS PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; CANCER; EFFECTOR CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN STRUCTURE; REGULATORY MECHANISM; REVIEW; STRUCTURE ANALYSIS;

AMINO ACID SEQUENCE; ANIMALS; HUMANS; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; NEOPLASMS; PROTEIN ISOFORMS; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS B-RAF; PROTO-ONCOGENE PROTEINS C-RAF; SEQUENCE HOMOLOGY, AMINO ACID; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 8444238236     PISSN: 14710072     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrm1498     Document Type: Review

References (99)

1. Rapp, U. R. et al. Structure and biological activity of v-raf, a unique oncogene transduced by a retrovirus. Proc. Natl Acad. Sci. USA 80, 4218-4222 (1983). First report on the oncogene v-raf as a sequence that is acquired by the murine retrovirus 3611-MSV.
2. Jansen, H. W., Ruckert, B., Lurz, R. & Bister, K. Two unrelated cell-derived sequences in the genome of avian leukemia and carcinoma inducing retrovirus MH2. EMBO J. 2, 1969-1975 (1983). First report on the sequences of v-mil and c-mil, later shown to be the avian C-RAF homologue.
3. Jansen, H. W. et al. Homologous cell-derived oncogenes in avian carcinoma virus MH2 and murine sarcoma virus 3611. Nature 307, 281-284 (1984).
4. Moelling, K., Heimann, B., Beimling, P., Rapp, U. R. & Sander, T. Serine- and threonine-specific protein kinase activities of purified gag-mil and gag-raf proteins. Nature 312, 558-561 (1984).
5. Marais, R. & Marshall, C. J. Control of the ERK MAP kinase cascade by Ras and Raf. Cancer Surv. 27, 101-125 (1996).
6. Barnier, J. V., Papin, C., Eychene, A., Lecoq, O. & Calothy, G. The mouse B-raf gene encodes multiple protein isoforms with tissue-specific expression. J. Biol. Chem. 270, 23381-23389 (1995).
7. Storm, S. M., Cleveland, J. L. & Rapp, U. R. Expression of raf family proto-oncogenes in normal mouse tissues. Oncogene 5, 345-351 (1990).
8. Luckett, J. C., Huser, M. B., Giagtzoglou, N., Brown, J. E. & Pritchard, C. A. Expression of the A-raf proto-oncogene in the normal adult and embryonic mouse. Cell Growth Differ. 11, 163-171 (2000).
9. Pritchard, C. A., Bolin, L., Slattery, R., Murray, R. & McMahon, M. Post-natal lethality and neurological and gastrointestinal defects in mice with targeted disruption of the A-Raf protein kinase gene. Curr. Biol. 6, 614-617 (1996).
10. Wojnowski, L. et al. Endothelial apoptosis in Braf-deficient mice. Nature Genet. 16, 293-297 (1997).
11. Wojnowski, L. et al. Oraf-1 protein kinase is essential for mouse development. Mech. Dev. 76, 141-149 (1998).
12. Huser, M. et al. MEK kinase activity is not necessary for Raf-1 function. EMBO J. 20, 1940-1951 (2001).
13. Mikula, M. et al. Embryonic lethality and fetal liver apoptosis in mice lacking the c-raf-1 gene. EMBO J. 20, 1952-1962 (2001).
14. Robbins, D. J. et al. MAP kinases ERK1 and ERK2: pleiotropic enzymes in a ubiquitous signaling network. Adv. Cancer Res. 63, 93-116 (1994).
15. Davies, H. et al. Mutations of the BRAF gene in human cancer. Nature 417, 949-954 (2002). Describes the first systematic genome-wide screen for oncogenes that was carried out by the Cancer Genome Project. The screen showed that B-RAF is mutated in approximately 7% of human cancers.
16. Allen, L. F., Sebolt-Leopold, J. & Meyer, M. B. CI-1040 (PD184352), a targeted signal transduction inhibitor of MEK (MAPKK). Semin. Oncol. 30, 105-116 (2003).
17. Patschinsky, T. & Bister, K. Structural analysis of normal and transforming mil(raf) proteins: effect of 5′-truncation on phosphorylation in vivo or in vitro. Oncogene 3, 357-364 (1988).
18. Marx, M. et al. A novel onoogene related to c-mil is transduced in chicken neuroretina cells induced to proliferate by infection with an avian lymphomatosis virus. EMBO J. 7, 3369-3373 (1988).
19. Wittinghofer, A. & Nassar, N. How Ras-related proteins talk to their effectors. Trends Biochem. Sci. 21, 488-491 (1996).
20. Hancock, J. F. Ras proteins: different signals from different locations. Nature Rev. Mol. Cell Biol. 4, 373-384 (2003).
21. Weber, C. K. et al. Mitogenic signaling of Ras is regulated by differential interaction with Raf isozymes. Oncogene 19, 169-176 (2000).
22. Tzivion, G. & Avruch, J. 14-3-3 proteins: active cofactors in cellular regulation by serine/threonine phosphorylation. J. Biol. Chem. 277, 3061-3064 (2002).
23. Ohillon, A. S. et al. Cyclic AMP-dependent kinase regulates Raf-1 kinase mainly by phosphorylation of serine 259. Mol. Cell. Biol. 22, 3237-3246 (2002).
24. Light, Y., Paterson, H. & Marais, R. 14-3-3 antagonizes Ras-mediated Raf-1 recruitment to the plasma membrane to maintain signaling fidelity. Mol. Cell. Biol. 22, 4984-4996 (2002).
25. Clark, G. J. et al. 14-3-3ζ negatively regulates raf-1 activity by interactions with the Raf-1 cysteine-rich domain. J. Biol. Chem. 272, 20990-20993 (1997).
26. Rommel, C. et al. Activated Ras displaces 14-3-3 protein from the amino terminus of c-Raf-1. Oncogene 12, 609-619 (1996).
27. Abraham, D. et al. Raf-1-associated protein phosphatase 2A as a positive regulator of kinase activation. J. Biol. Chem. 275, 22300-22304 (2000).
28. Jaumot, M. & Hancock, J. F. Protein phosphatases 1 and 2A promote Raf-1 activation by regulating 14-3-3 interactions. Oncogene 20, 3949-3958 (2001).
29. Ory, S., Zhou, M., Conrads, T. P., Veenstra, T. D. & Morrison, D. K. Protein phosphatase 2A positively regulates Ras signaling by dephosphorylating KSR1 and Raf-1 on critical 14-3-3 binding sites. Curr. Biol. 13, 1356-1364 (2003).
30. Mischak, H. et al. Negative regulation of Raf-1 by phosphorylation of serine 621. Mol. Cell. Biol. 16, 5409-5418 (1996).
31. Marais, R. et al. Requirement of Ras-GTP-Raf complexes for activation of Raf-1 by protein kinase C. Science 280, 109-112 (1998).
32. Chiloeches, A. et al. Regulation of Ras®GTP loading and Ras-Raf association in neonatal rat ventricular myocytes by G protein-coupled receptor agonists and phorbol ester. Activation of the extracellular signal-regulated kinase cascade by phorbol ester is mediated by Ras. J. Biol. Chem. 274, 19762-19770 (1999).
33. King, A. J. et al. The protein kinase Pak3 positively regulates Raf-1 activity through phosphorylation of serine 338. Nature 396, 180-183 (1998).
34. Chaudhary, A. et al. Phosphatidylinositol 3-kinase regulates Raf1 through Pak phosphorylation of serine 338. Curr. Biol. 10, 551-554 (2000).
35. Marais, R., Light, Y., Paterson, H. F. & Marshall, C. J. Ras recruits Raf-1 to the plasma membrane for activation by tyrosine phosphorylation. EMBO J. 14, 3136-3145 (1995).
36. Marais, R., Light, Y., Paterson, H. F., Mason, C. S. & Marshall, C. J. Differential regulation of Raf-1, A-Raf, and B-Raf by oncogenic ras and tyrosine kinases. J. Biol. Chem. 272, 4378-4383 (1997). Shows that whereas A-RAF and C-RAF require RAS binding and tyrosine phosphorylation by SRC to become fully activated, B-RAF does not require SRC for activation and is activated simply by RAS alone.
37. Wu, J. et al. Inhibition of the EGF-activated MAP kinase signaling pathway by adenosine 3′,5′-monophosphate. Science 262, 1065-1069 (1993).
38. Sldovar, M. F. et al. Phosphorylation of serine 43 is not required for inhibition of c-Raf kinase by the cAMP-dependent protein kinase. J. Biol. Chem. 275, 28688-28694 (2000).
39. Dumaz, N., Light, Y. & Marais, R. Cyclic AMP blocks cell growth through Raf-1-dependent and Raf-1-independent mechanisms. Mol. Cell. Biol. 22, 3717-3728 (2002).
40. Dumaz, N. & Marais, R. Protein kinase A blocks Raf-1 activity by stimulating 14-3-3 binding and blocking Raf-1 interaction with Ras. J. Biol. Chem. 278, 29819-29823 (2003).
41. Zimmermann, S. & Moelling, K. Phosphorylation and regulation of Raf by Akt (protein kinase B). Science 286, 1741-1744 (1999).
42. Tzivion, G., Luo, Z. & Avruch, J. Adimeric 14-3-3 protein is an essential cofactor for Raf kinase activity. Nature 394, 88-92 (1998).
43. Yip-Schneider, M. T. et al. Regulation of the Raf-1 kinase domain by phosphorylation and 14-3-3 association. Biochem. J. 351, 151-159 (2000).
44. Fabian, J. R., Daar, I. O. & Morrison, D. K. Critical tyrosine residues regulate the enzymatic and biological activity of Raf-1 kinase. Mol. Cell. Biol. 13, 7170-7179 (1993).
45. Hekman, M. et al. Dynamic changes in C-Raf phosphorylation and 14-3-3 protein binding in response to growth factor stimulation: differential roles of 14-3-3 protein binding sites. J. Biol. Chem. 279, 14074-14086 (2004).
46. Mason, C. S. et al. Serine and tyrosine phosphorylations cooperate in Raf-1, but not B-Raf actuation. EMBO J. 18, 2137-2148 (1999). Together with references 33 and 44, describes the N-region and the important differences in regulation between C-RAF and B-RAF.
47. Chow, Y. H. et al. Functional mapping of the N-terminal regulatory domain in the human Raf-1 protein kinase. J. Biol. Chem. 270, 14100-14106 (1995).
48. King, A. J., Wireman, R. S., Hamilton, M. & Marshall, M. S. Phosphorylation site specificity of the Pak-mediated regulation of Raf-1 and cooperativity with Src. FEBS Lett. 497, 6-14 (2001).
49. Tilbrook, P. A., Colley, S. M., McCarthy, D. J., Marais, R. & Klinken, S. P. Erythropoietin-stimulated Raf-1 tyrosine phosphorylation is associated with the tyrosine kinase Lyn in J2E erythroleukemic cells. Arch. Biochem. Biophys. 396, 128-132 (2001).
50. Tran, N. H. & Frost, J. A. Phosphorylation of Raf-1 by p21-activated kinase 1 and Src regulates Raf-1 autoinhibition. J. Biol. Chem. 278, 11221-11226 (2003).
51. Oehrl, W., Rubio, I. & Wetzker, R. Serine 338 phosphorylation is dispensable for activation of c-Raf1. J. Biol. Chem. 278, 17819-17826 (2003).
52. Sun, H., King, A. J., Diaz, H. B. & Marshall, M. S. Regulation of the protein kinase Raf-1 by oncogenic Ras through phosphatidylinositol 3-kinase, Cdc42/Rac and Pak. Curr. Biol. 10, 281-284 (2000).
53. Zang, M., Hayne, C. & Luo, Z. Interaction between active Pak1 and Raf-1 is necessary for phosphorylation and activation of Raf-1. J. Biol. Chem. 277, 4395-4405 (2002).
54. Chiloeches, A., Mason, C. S. & Marais, R. S338 phosphorylation of Raf-1 is independent of phosphatidylinositol 3-kinase and Pak3. Mol. Cell. Biol. 21, 2423-2434 (2001).
55. Zang, M. et al. Microtubule integrity regulates Pak leading to Ras-independent activation of Raf-1. Insights into mechanisms of Raf-1 activation. J. Biol. Chem. 276, 25157-25165 (2001).
56. Sutor, S. L., Vroman, B. T., Armstrong, E. A., Abraham, R. T. & Karnitz, L. M. A phosphatidylinositol 3-kinase-dependent pathway that differentially regulates c-Raf and A-Raf. J. Biol. Chem. 274, 7002-7010 (1999).
57. Chong, H., Lee, J. & Guan, K. L. Positive and negative regulation of Raf kinase activity and function by phosphorylation. EMBO J. 20, 3716-3727 (2001).
58. Zhang, B. H. & Guan, K. L. Activation of B-Raf kinase requires phosphorylation of the conserved residues Thr598 and Ser601. EMBO J. 19, 5429-5439 (2000). Describes the identification of the two phsophorylation sites in the activation-segment of the B-RAF kinase domain that are required for its activation and therefore reveals the positive regulation of B-RAF by phosphorylation.
59. Wan, P. T. et al. Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF. Cell 116, 855-867 (2004). Describes the solved crystal structure of B-RAF. First description of the structure of the B-RAF kinase domain. Provides insight into how B-RAF is regulated and why the mutations in cancer are activating.
60. Ikenoue, T. et al. Functional analysis of mutations within the kinase activation segment of B-Raf in human colorectal tumors. Cancer Res. 63, 8132-8137 (2003).
61. Li, S. & Sedivy, J. M. Raf-1 protein kinase activates the NF-κB transcription factor by dissociating the cytoplasmic NF-κB-IκB complex. Proc. Natl Acad. Sci. USA 90, 9247-9251 (1993).
62. Janosch, P. et al. Characterization of IκB kinases. IκB-α is not phosphorylated by Raf-1 or protein kinase C isozymes, but is a casein kinase II substrate. J. Biol. Chem. 271, 13868-13874 (1996).
63. Baumann, B. et al. Raf induces NF-κB by membrane shuttle kinase MEKK1, a signaling pathway critical for transformation. Proc. Natl Acad. Sci. USA 97, 4615-4620 (2000).
64. Galaktionov, K., Jessus, C. & Beach, D. Raf1 interaction witn Cdc25 phosphatase ties mitogenic signal transduction to cell cycle activation. Genes Dev. 9, 1046-1058 (1995).
65. Wang, S., Ghosh, R. N. & Chellappan, S. P. Raf-1 physically interacts with Rb and regulates its function: a link between mitogenic signaling and cell cycle regulation. Mol. Cell. Biol. 18, 7487-7498 (1998).
66. Wang, H. G., Rapp, U. R. & Reed, J. C. Bcl-2 targets the protein kinase Raf-1 to mitochondria. Cell 87, 629-638 (1996).
67. Wang, H. G., Takayama, S., Rapp, U. R. & Reed, J. C. Bcl-2 interacting protein, BAG-1, binds to and activates the kinase Raf-1. Proc. Natl Acad. Sci. USA 93, 7063-7068 (1996).
68. Troppmair, J. & Rapp, U. R. Raf and the road to cell survival: a tale of bad spells, ring bearers and detours. Biochem. Pharmacol. 66, 1341-1345 (2003).
69. Chen, J., Fuji, K., Zhang, L., Roberts, T. & Fu, H. Raf-1 promotes cell survival by antagonizing apoptosis signal-regulating kinase 1 through a MEK-ERK independent mechanism. Proc. Natl Acad. Sci. USA 98, 7783-7788 (2001).
70. Karasarides, M. et al. B-RAF is therapeutic target in melanoma. Oncogene 23, 6292-6298 (2004).
71. Houben, R. et al. Constitutive actuation of the Ras-Raf signaling pathway in metastatic melanoma is associated with poor prognosis. J. Carcinog. 3, 6 (2004).
72. Papin, C., Denouel, A., Calothy, G. & Eychene, A. Identification of signalling proteins interacting with B-Raf in the yeast two-hybrid system. Oncogene 12, 2213-2221 (1996).
73. Jaiswal, R. K., Moodie, S. A., Wolfman, A. & Landreth, G. E. The mitogen-activated protein kinase cascade is activated by B-Raf in response to nerve growth factor through interaction with p21 ras. Mol. Cell. Biol. 14, 6944-6953 (1994).
74. Catling, A. D., Reuter, C. W., Cox, M. E., Pareons, S. J. & Weber, M. J. Partial purification of a mitogen-activated protein kinase kinase activator from bovine brain. Identification as B-Raf or a B-Raf-associated activity. J. Biol. Chem. 269, 30014-30021 (1994).
75. Moodie, S. A., Paris, M. J., Kolch, W. & Wolfman, A. Association of MEK1 with p21ras®GMPPNP is dependent on B-Raf. Mol. Cell. Biol. 14, 7153-7162 (1994).
76. Pritchard, C. A., Samuels, M. L., Bosch, E. & McMahon, M. Conditionally oncogenic forms of the A-Raf and B-Raf protein kinases display different biological and biochemical properties in NIH 3T3 cells. Mol. Cell. Biol. 15, 6430-6442 (1995). Shows that the individual RAF isoforms differ in their ability to activate MEK in cells and therefore differ in their biological function. In this study, B-RAF is identified as the RAF isoform that activates MEK with the highest efficiency.
77. Wojnowski, L., Stancato, L. F., Lamer, A. C., Rapp, U. R. & Zimmer, A. Overlapping and specific functions of Braf and Craf-1 proto-oncogenes during mouse embryogenesis. Mech. Dev. 91, 97-104 (2000).
78. Mercer, K. et al. ERK signaling and oncogene transformation are not impaired in cells lacking A-Raf. Oncogene 21, 347-355 (2002).
79. Marshal, C. J. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80, 179-185 (1995).
80. Weber, J. D., Raben, D. M., Phillips, P. J. & Baldassare, J. J. Sustained activation of extracellular-signal-regulated kinase 1 (ERK1) is required for the continued expression of cyclin D1 in G1 phase. Biochem. J. 326, 61-68 (1997).
81. Woods, D. et al. Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1. Mol. Cell. Biol. 17, 5598-5611 (1997).
82. Kerkhoff, E. & Rapp, U. R. High-intensity Raf signals convert mitotic cell cycling into cellular growth. Cancer Res. 58, 1636-1640 (1998). References 81 and 82 show that the strength and duration of RAF kinase signalling is relevant for the biological outcome.
83. Kao, S., Jaiswal, R. K., Kolch, W. & Landreth, G. E. Identification of the mechanisms regulating the differential activation of the MAPK cascade by epidermal growth factor and nerve growth factor in PC12 cells. J. Biol. Chem. 276, 18169-18177 (2001).
84. Corbit, K. C. et al. Different protein kinase C isoforms determine growth factor specificity in neuronal cells. Mol. Cell. Biol. 20, 5392-5403 (2000).
85. Bogoyevitch, M. A., Marshall, C. J. & Sugden, P. H. Hypertrophic agonists stimulate the activities of the protein kinases c-Raf and A-Raf in cultured ventricular myocytes. J. Biol. Chem. 270, 26303-26310 (1995).
86. Alavi, A., Hood, J. D., Frausto, R., Stupack, D. G. & Cheresh, D. A. Role of Raf in vascular protection from distinct apoptotic stimuli. Science 301, 94-96 (2003).
87. Guan, K. L. et al. Negative regulation of the serine/threonine kinase B-Raf by Akt. J. Biol. Chem. 275, 27354-27359 (2000).
88. Morrison, D. K. KSR: a MARK scaffold of the Ras pathway? J. Cell Sci. 114, 1609-1612 (2001).
89. Morrison, D. K. & Davis, R. J. Regulation of MAP kinase signaling modules by scaffold proteins in mammals. Annu. Rev. Cell. Dev. Biol. 19, 91-118 (2003).
90. Pouyssegur, J., Volmat, V. & Lenormand, P. Fidelity and spatio-temporal control in MAP kinase (ERKs) signaling. Biochem. Pharmacol. 64, 755-763 (2002).
91. Anselmo, A. N., Bumeister, R., Thomas, J. M. & White, M. A. Critical contribution of linker proteins to Raf kinase activation. J. Biol. Chem. 277, 5940-5943 (2002).
92. Denouel-Galy, A. et al. Murine Ksr interacts with MEK and inhibits Ras-induced transformation. Curr. Biol. 8, 46-55 (1998).
93. Lanigan, T. M. et al. Human homologue of Drosophila CNK interacts with Ras effector proteins Raf and Rlf. FASEB J. 17, 2048-2060 (2003).
94. Li, W., Han, M. & Guan, K. L. The leucine-rich repeat protein SUR-8 enhances MAP kinase activation and forms a complex with Ras and Raf. Genes Dev. 14, 895-900 (2000).
95. Bonner, T. I. et al. Structure and biological activity of human homologs of the raf/mil oncogene. Mol. Cell. Biol. 5, 1400-1407 (1985).
96. Huebner, K. et al. Actively transcribed genes in the raf oncogene group, located on the X chromosome in mouse and human. Proc. Natl Acad. Sci. USA 83, 3934-3938 (1986).
97. Beck, T. W., Huleihel, M., Gunnel, M., Bonner, T. I. & Rapp, U.R. The complete coding sequence of the human A-raf-1 oncogene and transforming activity of a human A-raf carrying retrovirus. Nucleic Acids Res. 15, 595-609 (1987).
98. Ikawa, S. et al. B-raf, a new member of the raf family, is activated by DNA rearrangement. Mol. Cell. Biol. 8, 2651-2654 (1988).
99. Kumar, R. et al. BRAF mutations in metastatic melanoma: a possible association with clinical outcome. Clin. Cancer Res. 9, 3362-3368 (2003).